CA2420176A1 - Compositions et methodes pour le diagnostic et le traitement de tumeurs - Google Patents

Compositions et methodes pour le diagnostic et le traitement de tumeurs Download PDF

Info

Publication number
CA2420176A1
CA2420176A1 CA002420176A CA2420176A CA2420176A1 CA 2420176 A1 CA2420176 A1 CA 2420176A1 CA 002420176 A CA002420176 A CA 002420176A CA 2420176 A CA2420176 A CA 2420176A CA 2420176 A1 CA2420176 A1 CA 2420176A1
Authority
CA
Canada
Prior art keywords
seq
antibody
tat
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002420176A
Other languages
English (en)
Inventor
Wei-Qiang Gao
Paul Polakis
Jianyong Shou
Victoria Smith
Robert Soriano
P. Mickey Williams
Thomas D. Wu
Zemin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/fr
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/fr
Priority claimed from PCT/US2001/020118 external-priority patent/WO2002016429A2/fr
Priority claimed from US09/888,257 external-priority patent/US20030060612A1/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2001/025464 external-priority patent/WO2002016581A2/fr
Publication of CA2420176A1 publication Critical patent/CA2420176A1/fr
Abandoned legal-status Critical Current

Links

Abstract

L'invention concerne des compositions de matière servant au diagnostic et au traitement de tumeurs chez des mammifères, ainsi que des méthodes d'utilisation de ces compositions dans le même but.
CA002420176A 2000-08-24 2001-08-14 Compositions et methodes pour le diagnostic et le traitement de tumeurs Abandoned CA2420176A1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
PCT/US2000/023328 WO2001016318A2 (fr) 1999-09-01 2000-08-24 Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
USPCT/US00/23328 2000-08-24
PCT/US2001/006520 WO2001068848A2 (fr) 2000-03-01 2001-02-28 Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
USPCT/US01/06520 2001-02-28
USPCT/US01/20118 2001-06-22
PCT/US2001/020118 WO2002016429A2 (fr) 2000-08-24 2001-06-22 Compositions et procedes de diagnostic et traitement de tumeurs
US09/888,257 2001-06-22
US09/888,257 US20030060612A1 (en) 1997-10-28 2001-06-22 Compositions and methods for the diagnosis and treatment of tumor
PCT/US2001/025464 WO2002016581A2 (fr) 2000-08-24 2001-08-14 Compositions et methodes pour le diagnostic et le traitement de tumeurs

Publications (1)

Publication Number Publication Date
CA2420176A1 true CA2420176A1 (fr) 2002-02-28

Family

ID=27485927

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002420176A Abandoned CA2420176A1 (fr) 2000-08-24 2001-08-14 Compositions et methodes pour le diagnostic et le traitement de tumeurs

Country Status (4)

Country Link
JP (1) JP2004520808A (fr)
AU (1) AU2001284906A1 (fr)
CA (1) CA2420176A1 (fr)
MX (1) MXPA03001644A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2582552A1 (fr) * 2004-10-21 2006-05-04 Igf Oncology, Llc Toxines et radionucleides couples aux ligands du recepteur igf-1 pour le traitement d'un cancer
WO2007137187A2 (fr) * 2006-05-18 2007-11-29 Molecular Profiling Institute, Inc. Système et procédé destinés à déterminer une intervention médicale individualisée pour une pathologie
JP2012231786A (ja) * 2011-04-18 2012-11-29 Kyushu Univ 標的遺伝子の発現変化による食品機能成分及び医薬品感受性評価方法
US20190352335A1 (en) * 2016-12-19 2019-11-21 Hanmi Pharm. Co., Ltd. Brain targeting long-acting protein conjugate

Also Published As

Publication number Publication date
JP2004520808A (ja) 2004-07-15
AU2001284906A1 (en) 2002-03-04
MXPA03001644A (es) 2004-05-14

Similar Documents

Publication Publication Date Title
AU2003249014B2 (en) Compositions and methods for the diagnosis and treatment of tumor
US20030060612A1 (en) Compositions and methods for the diagnosis and treatment of tumor
CA2420140A1 (fr) Compositions et procedes de diagnostic et traitement de tumeurs
US20130210116A1 (en) Composition and methods for the diagnosis and treatment of tumor
US20090227776A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US6914130B2 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016581A2 (fr) Compositions et methodes pour le diagnostic et le traitement de tumeurs
AU2001286785B2 (en) Compositions and methods for the diagnosis and treatment of tumor
US8097700B2 (en) TAT294 polypeptides
AU2001286785A1 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2006230703A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20020161199A1 (en) Compositions and methods for the diagnosis and treatment of tumor
CA2420176A1 (fr) Compositions et methodes pour le diagnostic et le traitement de tumeurs
US20050159591A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20070031901A1 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2002254651A1 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003090600A2 (fr) Compositions et procedes permettant de diagnostiquer et de traiter une tumeur
ZA200408159B (en) Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued